Open Call SC1-HCO-10-2016: Support for Europe's Leading Health ICT SMEs
The business environment and sustainable business models for eHealth SMEs have been a major challenge when introducing innovations in new healthcare delivery. The scope is co-ordinating post R&D and offering support for developing business models, improving the maturity of the new products emerging from Europe's leading Health ICT SMEs, developing a pro-innovation approach to address legal conditions in Europe and globally on a case-by-case basis.
Read more ...
Open Call H2020-SMEINST-1-2015: Horizon 2020 Dedicated SME Instrument Phase 1 and 2
The dedicated SME instrument's supports close-to-market activities, with the aim to give a strong boost to breakthrough innovation. Highly innovative SMEs with a clear commercial ambition and a potential for high growth and internationalisation are the prime target.
Read more ...
Open Call H2020-ISSI-2015-1 for Integrating Society in Science and Innovation (ISSI-4-2015: On-Line Mechanisms for Knowledge-Based Policy Advice)
In a global perspective Europe can gain from effective knowledge-based decision-making, widening its knowledge base beyond science, not the least with regard to science, technology and innovation (STI) governance itself.
Read more ...
Open Call H2020-ISSI-2015-1 for Integrating Society in Science and Innovation (ISSI-3-2015: Knowledge Sharing Platform)
Evidence from Sixth Framework Programme Science and Society (S&S) and Seventh Framework Programme Science in Society (SiS) programmes shows that more consistent policy development in Science and Technology requires systematic cooperation and a shared knowledge base on which European, national and sub-national research and innovation policy decisions can be drawn from.
Read more ...
IMI Call for Proposals with Focus on Alzheimer's Disease, Diabetes, Patient Involvement
The Innovative Medicines Initiative (IMI) has launched its 5th Call for proposals under the IMI 2 programme. IMI 2 - Call 5 has a total budget of €95 million and features 6 topics. Of these, four focus on different aspects of Alzheimer's disease, one focuses on diabetic kidney disease, and one addresses patient input on assessments of the benefits and risks of medicines.
Read more ...
The business environment and sustainable business models for eHealth SMEs have been a major challenge when introducing innovations in new healthcare delivery. The scope is co-ordinating post R&D and offering support for developing business models, improving the maturity of the new products emerging from Europe's leading Health ICT SMEs, developing a pro-innovation approach to address legal conditions in Europe and globally on a case-by-case basis. 
The Innovative Medicines Initiative (IMI) has launched its 5th Call for proposals under the IMI 2 programme. IMI 2 - Call 5 has a total budget of €95 million and features 6 topics. Of these, four focus on different aspects of Alzheimer's disease, one focuses on diabetic kidney disease, and one addresses patient input on assessments of the benefits and risks of medicines.